Royal Bank of Canada’s ArriVent BioPharma AVBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1K Sell
24
-120
-83% -$5K ﹤0.01% 6562
2025
Q1
$3K Sell
144
-1,608
-92% -$33.5K ﹤0.01% 6150
2024
Q4
$47K Sell
1,752
-1,714
-49% -$46K ﹤0.01% 5247
2024
Q3
$81K Buy
3,466
+2,539
+274% +$59.3K ﹤0.01% 5022
2024
Q2
$17K Buy
927
+558
+151% +$10.2K ﹤0.01% 5750
2024
Q1
$7K Buy
+369
New +$7K ﹤0.01% 5909